EUVIMEDOpdag EUVIMED
Multizentrische StudieKohortenstudieOpen access · CC BY-NC-ND 4.0

CT ‐Based Biomarkers for Predicting Progressive Phenotypes in Interstitial Lung Diseases: A Retrospective Cohort Study

Ju Hyun Oh iD, Jin Woo Song iD, Jonathan Goldin, S Samuel Weigt iD, Augustine Chung iD, Jared D Wilkinson iD, Fereidoun Abtin, Lila Pourzand iD, Bianca Villegas, Jihey Lee, Kyungjong Lee iD, Grace Hyun J Kim iD

Respirology · 2026-11 · 31 (11) · 1134-1143

DOI: 10.1002/resp.70299 ↗

At a glance

Multizentrische Studie in Respirology, published online on 2026-08-14. Written by Ju Hyun Oh and 11 co-authors. Institution: Department of Pulmonary and Critical Care Medicine, Ajou University Medical Center, Ajou University School of Medicine, Suwon, Republic of Korea. Major MEDLINE topics: Lung Diseases, Interstitial, Tomography, X-Ray Computed, Lung. Cited 1 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Boehringer Ingelheim, National Research Foundation of Korea, Korea National Institute of Health research project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Objective Prediction of the progressive phenotype from baseline evaluation is challenging due to the variable clinical course of fibrosing interstitial lung disease (ILD). The aim of this study was to evaluate whether the Single Time Point Prediction (STP) score predicts disease progression better than other quantitative scores.

Methods

This is a retrospective two‐centre study including patients with ILD other than idiopathic pulmonary fibrosis (IPF). Using an automated quantification system, quantitative lung fibrosis (QLF), quantitative ground‐glass opacity (QGG), quantitative ILD (QILD; the sum of reticulation, honeycombing, and ground‐glass opacity), quantitative normal lung (QNL), and STP scores were measured. Disease progression (DP) was defined as an absolute decline in forced vital capacity (FVC) ≥ 5% or DL CO ≥ 10% predicted, death or lung transplantation.

Results

Of 245 patients, 137 (55.9%) progressed during follow‐up (median: 20.4 months). In the Kaplan–Meier analysis, patients with high QGG (≥ 10%), high QILD (≥ 30%), and high STP (≥ 30%) showed shorter DP free survival time than those without. After adjusting for age, sex, FVC, and types of non‐IPF ILD, QGG scores ≥ 10%, QILD ≥ 30%, and STP ≥ 30% remained significant predictors of progression (hazard ratio [HR] = 1.71, p = 0.024; HR = 1.73, p = 0.006; and HR = 1.58, p = 0.020, respectively). Furthermore, higher QILD and QGG scores in STP‐positive regions were independently associated with increased DP risk, whereas higher QNL in STP‐negative regions was associated with lower DP risk.

Conclusions

The STP score is a useful imaging biomarker for predicting DP and, when combined with conventional quantitative CT scores, may improve risk stratification in patients with non‐IPF ILD. image

Subjects

MeSH terms (MEDLINE)

Lung Diseases, InterstitialTomography, X-Ray ComputedLungHumansRetrospective StudiesFemaleDisease ProgressionMalePhenotypeBiomarkersAgedMiddle AgedPrognosisVital CapacityPredictive Value of TestsKaplan-Meier Estimate

Substances

Biomarkers

Authors and institutions

  • Department of Pulmonary and Critical Care Medicine, Ajou University Medical Center, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Radiologic Science, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Division of Pulmonary, Critical Care, Allergy and Immunology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Advanced Lung Disease and Lung Transplant, Inova Fairfax Medical Center, Falls Church, Virginia, USA.
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

ORCID profiles: Ju Hyun Oh, Jin Woo Song, S Samuel Weigt, Augustine Chung, Jared D Wilkinson, Lila Pourzand, Kyungjong Lee, Grace Hyun J Kim

Funding

  • Boehringer Ingelheim
  • National Research Foundation of Korea
  • Korea National Institute of Health research project
  • Korea Ministry of Environment
  • Ministry of Health & Welfare, Republic of Korea

Cite

APA

Oh, J. H., Song, J. W., Goldin, J., Weigt, S. S., Chung, A., Wilkinson, J. D., Abtin, F., Pourzand, L., Villegas, B., Lee, J., Lee, K., & Kim, G. H. J. (2026). CT ‐Based Biomarkers for Predicting Progressive Phenotypes in Interstitial Lung Diseases: A Retrospective Cohort Study. Respirology, 31(11), 1134-1143. https://doi.org/10.1002/resp.70299

Vancouver

Oh JH, Song JW, Goldin J, Weigt SS, Chung A, Wilkinson JD, et al. CT ‐Based Biomarkers for Predicting Progressive Phenotypes in Interstitial Lung Diseases: A Retrospective Cohort Study. Respirology. 2026;31(11):1134-1143. doi:10.1002/resp.70299

BibTeX
@article{Oh2026,
  author = {Oh, Ju Hyun and Song, Jin Woo and Goldin, Jonathan and Weigt, S Samuel and Chung, Augustine and Wilkinson, Jared D and Abtin, Fereidoun and Pourzand, Lila and Villegas, Bianca and Lee, Jihey and Lee, Kyungjong and Kim, Grace Hyun J},
  title = {CT ‐Based Biomarkers for Predicting Progressive Phenotypes in Interstitial Lung Diseases: A Retrospective Cohort Study},
  journal = {Respirology},
  year = {2026},
  volume = {31},
  number = {11},
  pages = {1134--1143},
  doi = {10.1002/resp.70299}
}
Start for free →